Sanara MedTech (SMTI) Long-Term Investments (2018 - 2026)

Sanara MedTech has reported Long-Term Investments for 8 years, with the latest figure at $14.2 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 32.5% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (up 32.5% YoY), and the FY2025 full-year result was $14.6 million, up 135.43% from the prior year.
• Long-Term Investments for Q1 2026 stood at $14.2 million, down from $14.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $14.6 million in Q4 2025, with the low at $3.1 million in Q2 2022.
• Historically, Long-Term Investments has averaged $6.5 million across 5 years, with a median of $3.1 million in 2022.
• Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 38.53% — and 2025, when it surged 246.61%.
• Sanara MedTech's Long-Term Investments stood at $3.1 million in 2022, then changed by 0.0% to $3.1 million in 2023, then jumped by 101.44% to $6.2 million in 2024, then soared by 135.43% to $14.6 million in 2025, then retreated by 3.16% to $14.2 million in 2026.
• The last three Long-Term Investments figures came in at $14.2 million (Q1 2026), $14.6 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.